These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Hu B; Chen W; Zhang Y; Shi H; Cheng D; Xiu Y Ann Nucl Med; 2020 May; 34(5):322-328. PubMed ID: 32130663 [TBL] [Abstract][Full Text] [Related]
5. Combining PD-L1 Expression and Standardized Uptake Values in FDG-PET/CT Can Predict Prognosis in Patients With Resectable Non-Small-Cell Lung Cancer. Miyazawa T; Otsubo K; Sakai H; Kimura H; Chosokabe M; Morikawa K; Furuya N; Marushima H; Kojima K; Mineshita M; Koike J; Saji H Cancer Control; 2021; 28():10732748211038314. PubMed ID: 34384268 [TBL] [Abstract][Full Text] [Related]
6. Association between Zhao L; Liu J; Wang H; Shi J Br J Radiol; 2021 Mar; 94(1119):20200397. PubMed ID: 33492995 [TBL] [Abstract][Full Text] [Related]
7. Relationship between SP142 PD-L1 Expression and Zhao L; Liu J; Shi J; Wang H Contrast Media Mol Imaging; 2020; 2020():2010924. PubMed ID: 32765198 [TBL] [Abstract][Full Text] [Related]
8. The correlation between PD-L1 expression and metabolic parameters of Xu X; Li J; Yang Y; Sang S; Deng S Clin Imaging; 2022 Sep; 89():120-127. PubMed ID: 35797878 [TBL] [Abstract][Full Text] [Related]
9. Correlation of PD-L1 expression on tumor cell and tumor infiltrating immune cell with 18F-fluorodeoxyglucose uptake on PET/computed tomography in surgically resected pulmonary adenocarcinoma. Hu B; Xiao J; Xiu Y; Fu Z; Shi H; Cheng D Nucl Med Commun; 2020 Mar; 41(3):252-259. PubMed ID: 32068670 [TBL] [Abstract][Full Text] [Related]
10. The Value of Vekens K; Everaert H; Neyns B; Ilsen B; Decoster L Clin Lung Cancer; 2021 Sep; 22(5):432-440. PubMed ID: 33879398 [TBL] [Abstract][Full Text] [Related]
11. 2-Deoxy-2-[fluorine-18] fluoro-d-glucose uptake on positron emission tomography is associated with programmed death ligand-1 expression in patients with pulmonary adenocarcinoma. Kaira K; Shimizu K; Kitahara S; Yajima T; Atsumi J; Kosaka T; Ohtaki Y; Higuchi T; Oyama T; Asao T; Mogi A Eur J Cancer; 2018 Sep; 101():181-190. PubMed ID: 30077123 [TBL] [Abstract][Full Text] [Related]
12. A Comprehensive Analysis of Programmed Cell Death Ligand-1 Expression With the Clone SP142 Antibody in Non-Small-Cell Lung Cancer Patients. Takada K; Toyokawa G; Okamoto T; Shimokawa M; Kozuma Y; Matsubara T; Haratake N; Akamine T; Takamori S; Katsura M; Shoji F; Oda Y; Maehara Y Clin Lung Cancer; 2017 Sep; 18(5):572-582.e1. PubMed ID: 28318951 [TBL] [Abstract][Full Text] [Related]
13. Jreige M; Letovanec I; Chaba K; Renaud S; Rusakiewicz S; Cristina V; Peters S; Krueger T; de Leval L; Kandalaft LE; Nicod-Lalonde M; Romero P; Prior JO; Coukos G; Schaefer N Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1859-1868. PubMed ID: 31214790 [TBL] [Abstract][Full Text] [Related]
14. The expression of PD-L1 protein as a prognostic factor in lung squamous cell carcinoma. Takada K; Okamoto T; Toyokawa G; Kozuma Y; Matsubara T; Haratake N; Akamine T; Takamori S; Katsura M; Shoji F; Oda Y; Maehara Y Lung Cancer; 2017 Feb; 104():7-15. PubMed ID: 28213003 [TBL] [Abstract][Full Text] [Related]
15. Negative Correlation Between Wu L; Liu J; Wang S; Bai M; Wu M; Gao Z; Li J; Yu J; Liu J; Meng X Front Endocrinol (Lausanne); 2022; 13():913631. PubMed ID: 35846323 [TBL] [Abstract][Full Text] [Related]
16. Predictive value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for PD-L1 expression in non-small cell lung cancer: A systematic review and meta-analysis. Seol HY; Kim YS; Kim SJ Thorac Cancer; 2020 Nov; 11(11):3260-3268. PubMed ID: 32951338 [TBL] [Abstract][Full Text] [Related]
17. New insight on the correlation of metabolic status on Wang Y; Zhao N; Wu Z; Pan N; Shen X; Liu T; Wei F; You J; Xu W; Ren X Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1127-1136. PubMed ID: 31502013 [TBL] [Abstract][Full Text] [Related]